DV
Dividend Vision

BBNX — Beta Bionics, Inc. Common Stock

Beta Bionics, Inc. Common Stock (BBNX)

Total return is -25.6% over the past 1.5 years, 56.1 points behind SPY at 30.5%. Its deepest 1-year drawdown was 72.3%.

This appears to be a single-stock holding rather than a diversified ETF, holding common stock in Beta Bionics, Inc. With no distribution rate or expense ratio data available and an inception date of January 30, 2025, the fund is newly launched and currently provides no dividend income to shareholders. This holding may appeal to investors seeking direct exposure to Beta Bionics' equity performance, though it lacks the diversification and income characteristics typical of traditional dividend ETFs.

BBNX key facts

Asset type
Stock
Asset class
Equity
Inception date
01/30/2025
Last close
$17.57
Market cap
$770,471,744
Average volume
935900.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.37